Company Filing History:
Years Active: 2017-2019
Title: The Innovative Mind of Debbie Liao: Advancements in Tumor-Targeted Drug Delivery
Introduction
Debbie Liao, an accomplished inventor based in San Diego, California, has made significant strides in the field of biomedical engineering. With three patents to her name, her work focuses primarily on developing innovative drug delivery systems that target tumors effectively. Her research holds the promise of transforming cancer treatment and improving patient outcomes.
Latest Patents
One of Debbie Liao's latest innovations is centered around a nanoparticle-based tumor-targeted drug delivery system. This aqueous tumor-targeting liposome nanoparticle composition features an aqueous dispersion of liposome nanoparticles that encapsulate an anti-cancer chemotherapeutic agent. The unique aspect of her invention is the incorporation of a legumain-targeting lipid that is combined with other micelle or vesicle-forming lipid materials. These components are designed to enhance the delivery of therapeutics directly to the tumor, with a focus on improving the efficacy and reducing side effects of cancer treatment.
Career Highlights
Debbie Liao has established herself as a key figure in the realm of health innovations through her role at The Scripps Research Institute. Here, she has engaged in groundbreaking research that not only highlights her inventive prowess but also contributes to the scientific community's understanding of targeted drug delivery mechanisms. Her patents stand as a testament to her commitment to fighting cancer and improving therapeutic approaches.
Collaborations
Throughout her career, Debbie has collaborated with distinguished colleagues, including Ralph A. Reisfeld and Rong Xiang. These collaborations have enriched her research endeavors and led to the development of innovative solutions that address complex medical challenges.
Conclusion
Debbie Liao's contributions to the field of tumor-targeted drug delivery exemplify the impact of innovation in healthcare. Her patents and collaborative efforts showcase her dedication to advancing cancer treatment methodologies. As she continues her work, the medical community looks forward to her further advancements that could potentially reshape the landscape of oncology.